下部尿路の尿流動態研究 : VI : Alpha adrenergic blockerの前立腺肥大症および膀胱頚部硬化症に対する応用

概要

論文の詳細を見る
Clinical application of the oral administration of phenoxybenzamine has been investigated in 41 patients with benign prostatic hypertrophy and 5 patients with bladder neck contracture. Residual amount of urine was reduced in 46% of cases after the treatment. The change in length of continence zone and the value of maximum urethral pressure, which were measured with urethral pressure profile, was not statistically significant comparing to the values prior to the treatment. The improvement of uroflowmetrogram and subjective symptom was observed in 76% and 91% of cases, respectively. The effective maintenance dose was found 7.5 to 15mg per day. Adverse effects were noted in 26% of cases. 49 cases were successfully treated with phenoxybenzamine, while 3 were not. The remaining 4 had to be changed to other medication due to the adverse effects. Phonoxybenzamine dose not shrink the prostatic adenoma per se, but functionally reduces the urethral resistance and alleviates the obstructive symptoms present in the lower urinary tract. Phonexybenzamine was found quite of promise ti achieve a satisfactory voiding in patients suffering from benign prostatic hypertrophy and bladder contracture also.
社団法人日本泌尿器科学会の論文
1978-10-20